Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D. Goldberg, . . . Juan Manuel Alonso‐Dominguez. (2023). First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia. Wiley.
Chicago Style (17th ed.) CitationMichael Boyiadzis, et al. First‐in‐human Study of JNJ‐63709178, a CD123/CD3 Targeting Antibody, in Relapsed/refractory Acute Myeloid Leukemia. Wiley, 2023.
MLA (9th ed.) CitationMichael Boyiadzis, et al. First‐in‐human Study of JNJ‐63709178, a CD123/CD3 Targeting Antibody, in Relapsed/refractory Acute Myeloid Leukemia. Wiley, 2023.
Warning: These citations may not always be 100% accurate.